Browse by author
Lookup NU author(s): Professor John IsaacsORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
In summary, alemtuzumab resulted in profound and prolonged lymphopenia, particularly affecting CD4+ T cells in a variety of autoimmune conditions. Critically, long-term follow-up data of more than 200 patients showed that alemtuzumab therapy was not associated with an obvious increase in morbidity or mortality.
Author(s): Isaacs JD
Publication type: Article
Publication status: Published
Journal: Transplantation Reviews
Year: 2003
Volume: 17
Issue: 4 (suppl. 1)
Pages: S12-S15
ISSN (print): 0955-470X
ISSN (electronic): 1557-9816
Publisher: WB Saunders Co.
URL: http://dx.doi.org/10.1016/j.trre.2003.07.006
DOI: 10.1016/j.trre.2003.07.006
Altmetrics provided by Altmetric